• The needs of allergic patients and how to address them

    View video presentations from an expert-faculty-driven satellite symposium presented by Professor Masatoshi Abe from EAACI 2018.

  • A discussion with Marcus Maurer

    What do you think of the most recent treatment algorithm for patients with CSU?
    Professor Marcus Maurer, an expert in CSU and last author of the recent EAACI/GA2LEN/EDF/WAO guideline revision, discusses topics in bite-size videos.

  • Symposium highlights from EAACI 2018

    The symposoium 'Global perspectives on chronic spontaneous urticaria (CSU) management: international recommendations vs. local practice' is availbale to view now, chaired by Professor Marcus Maurer, with an expert panel of Dr Désirée Larenas-Linnemann, Professor Elias Toubi and Dr Zuotao Zhao.

  • PCP checklist: an interactive tool

    How often do you see patients presenting with hives, but aren’t sure on the diagnosis? Could it be CSU?
    Use this interactive tool in every day practice to support your diagnosis decisions and ensure you’re asking your patients the right questions.

  • Case studies

    Doctor Montse Alvaro presents a case study of an 8-year-old girl who presents with a 3-month history of near-daily urticaria and asymmetrical facial swelling.
    Additional case studies from Marcus Maurer, Peter Schmid-Grendelmeier, Torsten Zuberbier and more.

 

Chronic Spontaneous Urticaria (CSU) Knowledge Centre

Welcome to the CSU Knowledge Centre. Featuring an overview of chronic spontaneous urticaria, offering pages that cover epidemiology, burden of disease, pathophysiology, assessment tools, treatment, paediatricsguidelines and fast facts. Delve into the Disease Overview to further your understanding of chronic spontaneous urticaria.

New: Video presentations from the sponsored satellite symposium ‘The needs of allergic patients and how to address them’ presented by Professor Masatoshi Abe at EAACI 2018.

Recently updated: The Disease Overview section has recently been updated with the latest EAACI guidance on the management of CSU. 


Information focusing on primary care, containing videos of patients’ first-hand experiences, video highlights and presentations from key events and real-life case studies presented by experts in the field is also available. Resources include: frequently asked questions in urticaria answered by key opinion leaders, quick reference guides including diagnostic algorithms, and information about the TARGET My Hives application.

Paediatric Urticaria

Paediatric Urticaria

Paediatric urticaria - its impact and how diagnosis and management compares to adult recommendations. Doctor Montse Alvaro discusses the challenge of managing paediatric patients where it's strongly recommended that first-generation H1-antihistamines are not prescribed.

Focus on Primary Care

Focus on Primary Care

Quick reference guides and case study videos dedicated to helping primary care practitioners diagnose, manage and treat. Professor Ana Gimenez-Arnau and Dr Dermot Ryan helped with the development of a downloadable checklist with algorithms, disease and drug information.

e-Learning

e-Learning

Access accredited CMEs 'Managing CSU and its comorbidities: from primary to secondary care' and 'EAACI 2017: The future of urticaria – advances in CSU research' and the e-Learning activity 'Case consults: Changing paradigms in the age of biologics'.

Symposia Media Library

Symposia Media Library

Watch highlights from key speakers including Marcus Maurer and Marter Ferrer at past events within the fields of dermatology and clinical immunology, such as PAAM, GUF, EADV, EAACI, RADLA and WCD.

Resources

Resources

FAQs such as how should the UAS7 be used, quick reference guides including a decision tree for wheals/angioedema and diagnostic tests recommended in the EAACI/GA2LEN/EDF/WAO guidelines are some of the resources available.

FAQs

FAQs

Frequently asked questions are answered by our expert faculty including Christian Vestergaard, Marta Ferrer and Ana Giménez-Arnau and include 'How do you chose which antihistamine to use in a newly diagnosed patient?'.

Fast Facts

Fast Facts

12 key points on understanding chronic spontaneous urticaria including: there are currently no validated useful biomarkers and there is currently no known cure with first-line treatment of H1-antihistamines, showing less than 50% symptomatic relief.

Treatment

Treatment

Discover first-, second- and third-line treatment options for CSU following the EAACI/GA2LEN/EDF/WAO recommended treatment algorithm. Detailing second generation H1-antihistamines and add-ons including omalizumab, ciclosporin A and montelukast.

Login/ Register Maximise Minimise